Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncology Research and Treatment|October 25, 2017
Cellular Immunotherapy in B-Cell MalignancyMark-Alexander Schwarzbich, Mathias Witzens-Harig
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
IbrutinibMark-Alexander Schwarzbich, Matthias Witzens-Harig
Oncology (Williston Park, N.Y.)|June 18, 2016
Allogeneic Transplantation for Chronic Lymphocytic Leukemia in the Age of Novel Treatment StrategiesMark-Alexander Schwarzbich, Fabienne McClanahan, John Gribben
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
IbrutinibAndriani Charalambous, Mark-Alexander Schwarzbich, Mathias Witzens-Harig
Leukemia & Lymphoma|March 22, 2016
Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab eraNicola Lehners, Isabelle Krämer, Mark-Alexander Schwarzbich, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2011
The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR-ABL tyrosine kinase inhibitorsMark-Alexander Schwarzbich, Michael Gutknecht, Julia Salih, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2016
Efficient Stem Cell Collection after Modified Cisplatin-Based Mobilization Chemotherapy in Patients with Diffuse Large B Cell LymphomaKatharina Lisenko, Martin Cremer, Mark-Alexander Schwarzbich, et al.
International Journal of Molecular Sciences|February 26, 2022
Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic TransplantationMark-Alexander Schwarzbich, Hao Dai, Lambros Kordelas, et al.
Transplantation|January 14, 2020
CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host DiseaseNicola Giesen, Mark-Alexander Schwarzbich, Katharina Dischinger, et al.
European Journal of Haematology|March 26, 2018
Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphomaKatharina Kriegsmann, Michael Rieger, Mark-Alexander Schwarzbich, et al.
Pageof 1